Skip to content

Frontlight ResearchEarly access

Trial site

Shanhai Cancer Center

Shanghai, Shanghai Municipality 200032, ChinaNot linked to an institution yet

1running trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Diffuse large B-cell lymphoma
Follicular lymphoma
Hodgkin lymphoma
Mantle cell lymphoma

Running trials

Active, not recruiting
A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients With B-cell Non-Hodgkin Lymphoma Who Have Been Previously Treated With Other Cancer Therapies
NCT03888105· Phase 2· Regeneron Pharmaceuticals· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Shanhai Cancer Center: trial site – Frontlight Research